Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 425 to 474 of 8289 in total
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
213\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4446.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5553.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24896\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative alpha-mannosidase c20orf31 precursor (ec 3.2.1.-). [source:swissprot;acc:q9bv94]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7777.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8326.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07056\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
214\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
core1 udp-galactose:n-acetylgalactosamine-alpha-r beta 1,3-galac. [source:refseq;acc:nm\_020156]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10492.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9804.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07014\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4074.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5086.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24827\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
215\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurochondrin. [source:refseq;acc:nm\_014284]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10492.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9804.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07014\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein p21a (k-ras 2a) (ki-ras) (c-k-ras). [source:swissprot;acc:p01116]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
16074\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12888.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24717\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
216\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein shoc-2 (ras-binding protein sur-8). [source:swissprot;acc:q9uq13]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
16071.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12886.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24714\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 12a; myosin phosphatase, target subunit 1. [source:refseq;acc:nm\_002480]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8973.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9597.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06962\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
217\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligopeptide transporter, small intestine isoform (peptide transporter 1) (intestinal h+/peptide cotransporter) (solute carrier family 15, member 1). [source:swissprot;acc:p46059]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7633.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8153.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06811\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 2 (ralgds-like factor) (ras-associated protein rab2l). [source:swissprot;acc:o15211]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16071.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12886.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24714\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
218\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide binding protein 2 (nbp 2). [source:swissprot;acc:q9y5y2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7266.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7759.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06774\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein p21/h-ras-1 (c-h-ras). [source:swissprot;acc:p01112]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
16070.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12886\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24712\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
219\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein n-ras. [source:swissprot;acc:p01111]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
16069.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12885.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24711\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u1 small nuclear ribonucleoprotein a (u1 snrnp a protein). [source:swissprot;acc:p09012]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7653.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8171.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06769\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
220\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
n-acetylglutamate synthase. [source:refseq;acc:nm\_153006]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9395.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10028.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06734\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
221\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10491.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9831.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06715\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
222\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9556.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10196.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06695\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
223\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tropomyosin alpha 3 chain (tropomyosin 3) (tropomyosin gamma). [source:swissprot;acc:p06753]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7600.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8107.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06672\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
224\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
malignant cell expression-enhanced gene/tumor progression-enhanc. [source:refseq;acc:nm\_024298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6228.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5839.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06662\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
225\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tropomyosin 1 alpha chain (alpha-tropomyosin). [source:swissprot;acc:p09493]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8109.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06649\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
226\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ninein (gsk3b interacting protein). [source:refseq;acc:nm\_016350]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7393.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7880.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06591\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
227\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5656.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6028.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06582\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
228\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein b". [source:swissprot;acc:p08579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7671.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8176.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06582\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
229\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5669.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6040.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06546\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
230\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
microsomal signal peptidase 18 kda subunit (ec 3.4.-.-) (spase 18 kda subunit) (spc18) (endopeptidase sp18). [source:swissprot;acc:p21378]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7789.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8298.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06529\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
231\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj820b18.1 (similar to nuclear cap binding protein) (fragment). [source:sptrembl;acc:q8wwk2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7650.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8148.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06512\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
232\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9465.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10081.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06506\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
233\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10519.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9877.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06495\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9035\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7279.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24114\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
234\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7647.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8143.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06489\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase, 52kda, polypeptide 1; ribosomal protein s6 kinase, 52kd, polypeptide 1. [source:refseq;acc:nm\_012424]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5181.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6410.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.23728\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
235\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tropomyosin alpha 4 chain (tropomyosin 4) (tm30p1). [source:swissprot;acc:p07226]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7630.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8125.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06487\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
236\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
spliceosomal u5 snrnp-specific 15 kda protein (dim1 protein homolog) (thioredoxin-like u5 snrnp protein u5-15kd). [source:swissprot;acc:o14834]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4723.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5828.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23392\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat domain 26. [source:refseq;acc:nm\_025160]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8731.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9296.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06468\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
237\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8530.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9081.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06457\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm5. [source:swissprot;acc:q9y4y9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4567.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5631.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23301\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/